Grafts and hepatitis C virus: maximizing the benefit.
Mottershead
Marcus
M
Neuberger
James
J
D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D015276:Health Care Rationing; D006526:Hepatitis C / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008019:Life Style; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000473:pathology; D016031:Liver Transplantation / Q000379:methods / Q000473:pathology / Q000706:statistics & numerical data*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012008:Recurrence; D016019:Survival Analysis
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid